Kelley M. Kidwell

6.3k total citations · 1 hit paper
163 papers, 4.2k citations indexed

About

Kelley M. Kidwell is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Kelley M. Kidwell has authored 163 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 34 papers in Cancer Research and 33 papers in Genetics. Recurrent topics in Kelley M. Kidwell's work include Breast Cancer Treatment Studies (25 papers), Estrogen and related hormone effects (23 papers) and Statistical Methods in Clinical Trials (20 papers). Kelley M. Kidwell is often cited by papers focused on Breast Cancer Treatment Studies (25 papers), Estrogen and related hormone effects (23 papers) and Statistical Methods in Clinical Trials (20 papers). Kelley M. Kidwell collaborates with scholars based in United States, Canada and Taiwan. Kelley M. Kidwell's co-authors include Adeyiza O. Momoh, N. Lynn Henry, Robert H. Bartlett, Daniel F. Hayes, Kevin C. Chung, Gail M. Annich, Matthew M. Davis, Folafoluwa O. Odetola, Matthew L. Paden and Jeffrey H. Kozlow and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Circulation.

In The Last Decade

Kelley M. Kidwell

155 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of Hospital-Level Volume of Extracorporeal Membrane Oxygenation Cases and Mortality. Analysis of the Extracorporeal Life Support Organization Registry

2015 432 citations Ryan P. Barbaro, Folafoluwa O. Odetola et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kelley M. Kidwell United States	35	1.2k	914	900	746	598	163	4.2k
Geoff P. Delaney Australia	36	1.8k 1.5×	762 0.8×	1.1k 1.3×	1.8k 2.4×	478 0.8×	232	6.2k
Marcela G. del Carmen United States	47	1.4k 1.1×	1.6k 1.7×	447 0.5×	792 1.1×	604 1.0×	221	6.9k
Sjoerd G. Elias Netherlands	43	1.7k 1.4×	677 0.7×	504 0.6×	1.0k 1.4×	617 1.0×	159	4.9k
Russell S. Berman United States	38	2.1k 1.8×	960 1.1×	713 0.8×	735 1.0×	1.7k 2.9×	180	5.8k
Chris Brown Australia	36	1.6k 1.3×	1.0k 1.1×	347 0.4×	1.3k 1.8×	705 1.2×	134	5.1k
Rebecca M. Minter United States	37	1.8k 1.5×	2.7k 2.9×	360 0.4×	899 1.2×	449 0.8×	154	5.9k
Dimitriοs Schizas Greece	32	1.4k 1.1×	1.7k 1.9×	475 0.5×	1.2k 1.5×	929 1.6×	349	4.7k
Myung‐Shin Sim United States	35	1.8k 1.5×	527 0.6×	983 1.1×	815 1.1×	1.3k 2.1×	114	4.3k
Sarkis Meterissian Canada	36	2.5k 2.1×	1.4k 1.5×	1.8k 2.0×	533 0.7×	1.5k 2.6×	167	6.1k
Barbara A. Goff United States	57	2.4k 2.0×	2.6k 2.9×	904 1.0×	1.1k 1.5×	1.4k 2.3×	231	10.2k

Countries citing papers authored by Kelley M. Kidwell

Since Specialization

Citations

This map shows the geographic impact of Kelley M. Kidwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelley M. Kidwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelley M. Kidwell more than expected).

Fields of papers citing papers by Kelley M. Kidwell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelley M. Kidwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelley M. Kidwell. The network helps show where Kelley M. Kidwell may publish in the future.

Co-authorship network of co-authors of Kelley M. Kidwell

This figure shows the co-authorship network connecting the top 25 collaborators of Kelley M. Kidwell. A scholar is included among the top collaborators of Kelley M. Kidwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelley M. Kidwell. Kelley M. Kidwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Walton, Maureen A., Laura Seewald, Patrick M. Carter, et al.. (2025). Adaptive interventions for alcohol misuse and violent behaviors among adolescents and emerging adults in the emergency department: Outcomes from a sequential multiple assignment randomized controlled trial. Drug and Alcohol Dependence. 270. 112615–112615.

Kidwell, Kelley M., Zeb R. Zacharias, Jon C. D. Houtman, et al.. (2025). Pilot Study of Cannabidiol for Treatment of Aromatase Inhibitor‐Associated Musculoskeletal Symptoms in Breast Cancer. Cancer Medicine. 14(15). e71117–e71117. 2 indexed citations

Tao, Xueting, et al.. (2024). Impact of chemotherapy-induced peripheral neuropathy permanence on patients' preference to discontinue chemotherapy.. Journal of Clinical Oncology. 42(16_suppl). 12046–12046. 1 indexed citations

Kidwell, Kelley M., et al.. (2024). The impact of cannabidiol (CBD) on aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS).. Journal of Clinical Oncology. 42(16_suppl). e24060–e24060. 1 indexed citations

Kidwell, Kelley M., Jennifer J. Griggs, Elena M. Stoffel, et al.. (2023). Effects of cancer type and sex on genetic testing for clinician recommendation and uptake. SHILAP Revista de lepidopterología. 19(12). 23–23. 1 indexed citations

Kidwell, Kelley M., et al.. (2023). Psychosocial factors impacting barriers and motivators to cancer genetic testing. Cancer Medicine. 12(8). 9945–9955. 8 indexed citations

Li, Yajing, et al.. (2023). Ovarian Function Suppression in Premenopausal Women With Concurrent Endocrine Therapy Use. Clinical Breast Cancer. 23(4). 454–460. 6 indexed citations

Griggs, Jennifer J., Ken Resnicow, Kelley M. Kidwell, et al.. (2023). The Michigan Genetic Hereditary Testing (MiGHT) study’s innovative approaches to promote uptake of clinical genetic testing among cancer patients: a study protocol for a 3-arm randomized controlled trial. Trials. 24(1). 105–105. 4 indexed citations

Drake, Christopher L., David A. Kalmbach, Philip Cheng, et al.. (2022). Sleep to Reduce Incident Depression Effectively (STRIDE): study protocol for a randomized controlled trial comparing stepped-care cognitive-behavioral therapy for insomnia versus sleep education control to prevent major depression. Trials. 23(1). 967–967. 6 indexed citations

10.

Brummett, Chad M., et al.. (2022). Association between nociplastic pain and premature endocrine therapy discontinuation in breast cancer patients. Breast Cancer Research and Treatment. 197(2). 397–404. 5 indexed citations

11.

Hertz, Daniel L., Julie A. Douglas, Robert M. Miller, et al.. (2022). Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms. Supportive Care in Cancer. 30(10). 8059–8067. 5 indexed citations

12.

Kurlander, Jacob E., Kelley M. Kidwell, Sarah L. Krein, et al.. (2022). Development of a multicomponent implementation strategy to reduce upper gastrointestinal bleeding risk in patients using warfarin and antiplatelet therapy, and protocol for a pragmatic multilevel randomized factorial pilot implementation trial. SHILAP Revista de lepidopterología. 3(1). 8–8. 5 indexed citations

13.

Fang, Fang, et al.. (2021). SLCO1B3 Polymorphisms and Clinical Outcomes in Kidney Transplant Recipients Receiving Mycophenolate. Pharmacogenomics. 22(17). 1111–1120. 2 indexed citations

14.

Hertz, Daniel L., Kelley M. Kidwell, Feng Li, et al.. (2018). Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy. Clinical Cancer Research. 24(15). 3602–3610. 45 indexed citations

15.

Kidwell, Kelley M., et al.. (2018). Ado-Trastuzumab Emtansine-Induced Pulmonary Toxicity: A Single-Institution Retrospective Review. Case Reports in Oncology. 11(2). 527–533. 10 indexed citations

16.

González, Maria E., Stephanie L. Skala, Mai Tran, et al.. (2018). CCN6 regulates IGF2BP2 and HMGA2 signaling in metaplastic carcinomas of the breast. Breast Cancer Research and Treatment. 172(3). 577–586. 21 indexed citations

17.

Henry, N. Lynn, Kelly Speth, Anneleen Lintermans, et al.. (2017). Associations Between Patient and Anthropometric Characteristics and Aromatase Inhibitor Discontinuation. Clinical Breast Cancer. 17(5). 350–355.e4. 11 indexed citations

18.

Barbaro, Ryan P., Folafoluwa O. Odetola, Kelley M. Kidwell, et al.. (2015). Association of Hospital-Level Volume of Extracorporeal Membrane Oxygenation Cases and Mortality. Analysis of the Extracorporeal Life Support Organization Registry. American Journal of Respiratory and Critical Care Medicine. 191(8). 894–901. 432 indexed citations breakdown →

19.

Paoletti, Costanza, Yufeng Li, Maria C. Muñiz, et al.. (2015). Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019. Clinical Cancer Research. 21(12). 2771–2779. 75 indexed citations

20.

Paoletti, Costanza, Maria C. Muñiz, Dafydd G. Thomas, et al.. (2014). Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer. Clinical Cancer Research. 21(11). 2487–2498. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact